Moreover, NfL remains an exploratory biomarker of disease activity in Huntington’s disease, and future studies would be enhanced by the incorporation of additional measures such as caudate thinning on volumetric MRI.84 Inclusion of MRI would also enable participants to be stratified according to the recent HD-ISS criteria.53 This evidence concerns the gene NEFL and juvenile Huntington disease.